DCN and endometrioid adenocarcinoma: Decreased decorin expression was observed in urothelial carcinoma, skin squamous and basal cell carcinoma, mammary lobular and ductal carcinoma, cervix adenocarcinoma, serous or mucinous cystadenocarcinoma and ovarium endometrioid carcinoma, colon, kidney, pancreas, prostate, rectum and the stomach, and embryonal carcinoma and seminoma of the testis (60).